Pharmacogenetics

"Pharmacogenetics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A branch of genetics which deals with the genetic variability in individual responses to drugs and drug metabolism (BIOTRANSFORMATION).

Descriptor ID	D010597
MeSH Number(s)	H01.158.273.343.750 H01.158.703.052 H02.628.479
Concept/Terms	Pharmacogenetics Pharmacogenetics Pharmacogenomics Pharmacogenomics

Below are MeSH descriptors whose meaning is more general than "Pharmacogenetics".

Natural Sciences [H]
Natural Science Disciplines [H01]
Biological Science Disciplines [H01.158]
Biology [H01.158.273]
Genetics [H01.158.273.343]
Pharmacogenetics [H01.158.273.343.750]
Pharmacology [H01.158.703]
Pharmacogenetics [H01.158.703.052]
Health Occupations [H02]
Pharmacology [H02.628]
Pharmacogenetics [H02.628.479]

Below are MeSH descriptors whose meaning is related to "Pharmacogenetics".

Below are MeSH descriptors whose meaning is more specific than "Pharmacogenetics".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Pharmacogenetics" by people in this website by year, and whether "Pharmacogenetics" was a major or minor topic of these publications.

Bar chart showing 40 publications over 17 distinct years, with a maximum of 4 publications in 2015 and 2018 and 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	0	1	1
2006	1	0	1
2008	0	2	2
2009	1	0	1
2010	2	0	2
2012	0	1	1
2013	1	0	1
2014	1	1	2
2015	3	1	4
2016	2	1	3
2017	2	1	3
2018	0	4	4
2019	1	2	3
2020	1	2	3
2021	1	3	4
2022	0	2	2
2023	1	2	3

Below are the most recent publications written about "Pharmacogenetics" by people in Profiles.

Hernandez-Martinez V, Duconge J, Rua?o G. An Expiration Date for Pharmacogenetic Test Results and Prescribing Guidance? J Appl Lab Med. 2023 07 05; 8(4):826-830.

View in: PubMed
Wen YF, Brundage RC, Roman YM, Culhane-Pera KA, Straka RJ. Population pharmacokinetics, pharmacodynamics and pharmacogenetics modelling of oxypurinol in Hmong adults with gout and/or hyperuricemia. Br J Clin Pharmacol. 2023 10; 89(10):2964-2976.

View in: PubMed
Telisnor G, DeRemer DL, Frimpong E, Agyare E, Allen J, Ricks-Santi L, Han B, George T, Rogers SC. Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans. J Natl Med Assoc. 2023 Apr; 115(2):164-174.

View in: PubMed
Morales-Borges RH, Gonzalez MJ, Duconge J, Minich DM. N-Acetyl Cysteine and Glutathione in Health and Cancer-Pharmacogenomics, Research, and Clinical Practice: Hypothesis and Review. Altern Ther Health Med. 2022 Oct; 28(7):169-177.

View in: PubMed
Anderson AN, Chan AR, Roman YM. Pharmacogenomics and clinical cultural competency: pathway to overcome the limitations of race. Pharmacogenomics. 2022 04; 23(6):363-370.

View in: PubMed
Roman Y. The United States 2020 Census data: implications for precision medicine and the?research landscape. Per Med. 2022 01; 19(1):5-8.

View in: PubMed
Duconge J, Santiago E, Hernandez-Suarez DF, Moner? M, L?pez-Reyes A, Rosario M, Renta JY, Gonz?lez P, Ileana Fern?ndez-Morales L, Antonio V?lez-Figueroa L, Arce O, Mar?n-Maldonado F, Nu?ez H, Melin K, Scott SA, Rua?o G. Pharmacogenomic polygenic risk score for clopidogrel responsiveness among Caribbean Hispanics: A candidate gene approach. Clin Transl Sci. 2021 11; 14(6):2254-2266.

View in: PubMed
Sangkuhl K, Claudio-Campos K, Cavallari LH, Agundez JAG, Whirl-Carrillo M, Duconge J, Del Tredici AL, Wadelius M, Rodrigues Botton M, Woodahl EL, Scott SA, Klein TE, Pratt VM, Daly AK, Gaedigk A. PharmVar GeneFocus: CYP2C9. Clin Pharmacol Ther. 2021 09; 110(3):662-676.

View in: PubMed
McCarthy MJ, Chen Y, Demodena A, Leckband SG, Fischer E, Golshan S, Suppes T, Kelsoe JR. A prospective study to determine the clinical utility of pharmacogenetic testing of veterans with treatment-resistant depression. J Psychopharmacol. 2021 Aug; 35(8):992-1002.

View in: PubMed
Hernandez-Suarez DF, Melin K, Marin-Maldonado F, Nunez HJ, Gonzalez AF, Gonzalez-Sepulveda L, Rivas-Tumanyan S, Naik H, Rua?o G, Scott SA, Duconge J. Implementing a pharmacogenetic-driven algorithm to guide dual antiplatelet therapy (DAPT) in Caribbean Hispanics: protocol for a non-randomised clinical trial. BMJ Open. 2020 08 06; 10(8):e038936.

View in: PubMed

People

Explore

Similar Concepts

Top Journals